Glooko - About the company
Glooko is a series F company based in Palo Alto (United States), founded in 2010. It operates as a Glucose meter and mobile app for diabetes management. Glooko has raised $201M in funding from investors like Social Capital, Canaan and Georgian. The company has 259 active competitors, including 32 funded and 5 that have exited. Its top competitors include companies like BeatO, Health2Sync and January.
Company Details
Glooko is a diabetes management solution for patients, health systems, and payer groups. Glooko’s products enable clinicians to remotely access their patients’ blood glucose readings and other related data, and optimize their insulin therapy. The company’s System allows people with diabetes to download their glucose readings to their mobile devices. According to the company, their population management web app offers diabetes-centric analytics and supplies insightful reports, graphs and pattern-triggered notifications to patients, health systems and payers. Partners include Abbott, Roche, LifeScan, Medtronic, Omnipod, Bayer, Nipro, and Arkray among others. Glooko and Diasend got merged in September 2016 and the combined companies operate under the Glooko moniker.
- Website
- glooko.com
- Social
- Registered Address
- Mountain View, California
Key Metrics
Founded Year
2010
Location
Palo Alto, United States
Stage
Series F
Total Funding
$201M in 8 rounds
Latest Funding Round
Investors
Ranked
2nd among 259 active competitors
Employee Count
239 as on May 31, 2026
Investment & Acquisitions
Legal entities associated with Glooko
Glooko is associated with 4 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Glooko d.o.o. CIN: 78124956649 , Croatia, Active | Sep 21, 2017 | $4.91M (As on Dec 31, 2024) | - | |
GLOOKO, INC. CIN: 32067000177 , United States, Active | Sep 28, 2021 | - | - | - |
Glooko AB CIN: 0788.501.815 , Belgium, Active | Jul 11, 2022 | - | - | - |
GLOOKO, INC. CIN: 273873317 , United States, Active | Jun 28, 2010 | - | 84 (As on Dec 31, 2024) | - |
Sign up to download Glooko's company profile
Glooko's funding and investors
Glooko has raised a total funding of $201M over 8 rounds. Its first funding round was on Nov 10, 2011. Its latest funding round was a Series F round on Oct 10, 2024 for $*****. 3 investors participated in its latest round. Glooko has 14 institutional investors and 9 angel investors.
Here is the list of recent funding rounds of Glooko:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 10, 2024 | 9590227 | Series F | 4283422 | 9896612 | 2669155 | 8767646 |
Mar 16, 2021 | 7391324 | Series D | 1888490 | 6247750 | 1536247 | |
Jun 27, 2017 | 6392067 | Series C | 8722829 | 1150617 |
Access funding benchmarks and valuations. Sign up today!View details of Glooko's funding rounds and investors
Glooko's founders and board of directors
Founder? Claim ProfileHere are the details of Glooko's key team members:
- Mike Alvarez: CEO of Glooko. Contact Info: 1 email address
Glooko's Board of Directors
Glooko's board has 19 active members. Charles Boorady, Simon Chong, Komathi Stem, Alfonso Zulueta, Clay Davidson, Wende Hutton, Tracy Bahl, Mike Doherty, Adam Hameed, Ed Marshall, David Pass, Enrique Conterno, Zach henderson, Komathi Stern, Steve Lien, Russ Johannesson, Prakash Menon, Christina Dickerson and Mark Beucler are independent board members.Here is the list of Glooko's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 4y 11m | |
ell{urn | Independent board member | - | Current | 6y 4m |
zsmzanf | Independent board member | - | Current | 1y 8m |
erkqgvi | Independent board member | - | Current | 9y 9m |
wduomhy | Independent board member | - | Current | 9y 7m |
cvpkqeq | Independent board member | - | Current | 3y 4m |
pq{{aaw | Independent board member | - | Current | 5y 2m |
clehkqz | Independent board member | - | Current | 8y 3m |
kshb{fv | Independent board member | - | Current | 9y 7m |
ijnviqg | Independent board member | - | Current | 5y 8m |
zmvzqsp | Independent board member | - | Current | 7y 3m |
aqby{ut | Independent board member | - | Current | 7y 1m |
ymevgnv | Independent board member | - | Current | 2y 8m |
urutuvj | Independent board member | - | Current | 2y 1m |
ytcyheg | Independent board member | - | Current | 8y 6m |
m{bxqdc | Independent board member | - | Current | 2y 2m |
kfpq{vr | Independent board member | - | Current | 4y 3m |
cdusvcm | Independent board member | - | Current | 2y 8m |
guo{nnh | Independent board member | - | Current | 5y 7m |
View details of Glooko's Founder profiles and Board Members
Glooko's employee count trend
Glooko has 239 employees as of May 26. Here is Glooko's employee count trend over the years:
Uncover Glooko's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Glooko's Competitors and alternates
Top competitors of Glooko include BeatO, Health2Sync and January. Here is the list of Top 10 competitors of Glooko, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of a smartphone-enabled glucometer and diabetes management app | $50.8M | 75/100 | ||
2nd | Glooko 2010, Palo Alto (United States), Series F | Glucose meter and mobile app for diabetes management | $201M | 67/100 | |
3rd |  Health2Sync 2013, Taipei (Taiwan), Series C | Provider of an app for tracking blood glucose level | $30.5M | 65/100 | |
4th | January 2017, San Francisco (United States), Series B | AI-powered precision health platform delivering personalized insights and recommendations | $28.3M | 54/100 | |
5th | Tidepool 2012, San Francisco (United States), Seed | Diabetes data management platform empowering accessible, actionable, and meaningful insights | $1.5M | 54/100 | |
6th |  Dr. Diary Co 2017, Seoul (South Korea), Series B | Provider of app for diabetes management | $12.2M | 50/100 | |
7th | LibreLinkUp 2016, Orlando (United States), Unfunded | Provider of diabetes management platform for patients | - | - | 46/100 |
8th | MyWay Digital Health 2017, Dundee (United Kingdom), Series A | Online platform for diabetes care and management | $4.05M | 46/100 | |
9th | Provider of app for blood glucose management | - | 46/100 | ||
10th | InsulCloud 2014, Madrid (Spain), Series A | Smart device for checking insulin adherence | $4.22M | 46/100 |
_1573650474211.webp?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Glooko's competitors? Click here to see the top ones
Glooko's Investments and acquisitions
Glooko has acquired 3 companies including Monarch Medical Technologies, xbird and Diasend. Glooko has not made any investments as of now.Here is the list of its acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Sep 23, 2025 | Acquisition | 2003 | Charlotte (United States) | |
Jan 31, 2022 | Acquisition | 2015 | Berlin (Germany) | |
Sep 12, 2016 | Acquisition | 2005 | Chicago (United States) |
Want to know more about where corporates are investing? Sign up today!See all acquisitions by Glooko
News related to Glooko
Filter this listMedia has covered Glooko for a total of 8 events in the last 1 year, 3 of them have been about company updates and 1 about partnerships.
•
•
•
Glooko and mylife Diabetes Care expand diabetes data management collaborationBusiness Wire•May 12, 2026•mylife Diabetescare, Glooko
•
•
Glooko Appoints Former UCSF Health CEO and National Healthcare Leader Mark Laret to Board of DirectorsBusiness Wire•Feb 03, 2026•Glooko
•
Glooko Acquires Monarch Medical Technologiesintelligence360•Oct 24, 2025•Monarch Medical Technologies, Glooko
•
Glooko Acquires Monarch Medical to Unify Diabetes ManagementHIT Consultant•Sep 23, 2025•Monarch Medical Technologies, Glooko
•
Caregentic Names Russ Johannesson as CEO to Drive ExpansionHIT Consultant•Apr 18, 2025•Caregentic, Glooko
•
Glooko integrates diabetes management platform with Abbott FreeStyle LibreDrug Delivery Business•Mar 25, 2025•Glooko, Abbott
•
Glooko Integrates Abbott FreeStyle Libre CGM, Enhancing Diabetes ManagementHIT Consultant•Mar 24, 2025•Glooko, Abbott
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Glooko
Explore our recently published companies
- WebyCare - Krishna based, 2021 founded, Unfunded company
- Irene-Turner - 2006 founded, Unfunded company
- Airtac-Samux - India based, Unfunded company
- PMD Chemicals - Coventry based, 1959 founded, Unfunded company
- Dum Safar Biryani - Noida based, 2025 founded, Unfunded company
- Everest - Warren based, 1973 founded, Public company
